Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8779108 Targeted binding agents against B7-H1

Patent 8779108 was granted and assigned to Medimmune Limited on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Melanie Boyle0

Laura Sekirov0

Marat Alimzhanov0

Matthieu Chodorge0

Michelle Morrow0

Ross A. Stewart0

Scott Hammond0

Christophe Queva0

...

Date of Patent

July 15, 2014

0

Patent Application Number

135115380

Date Filed

November 24, 2010

0

Patent Citations Received

US Patent 11746103 ALK-5 inhibitors and uses thereof

US Patent 11787859 TIM-3 antagonists for the treatment and diagnosis of cancers

US Patent 11801240 Combination therapies and uses thereof

US Patent 11827704 Antibody molecules to PD-1 and uses thereof

0

US Patent 11834448 2-amino-quinoline derivatives

0

US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

0

US Patent 11866495 Anti-CEACAM6 antibodies and uses thereof

0

US Patent 11918649 PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds

0

...

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8779108 Targeted binding agents against B7-H1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool